BioXcel Therapeutics Inc (BTAI)
2.65
+0.04
(+1.53%)
USD |
NASDAQ |
Apr 26, 09:34
BioXcel Therapeutics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
September 29, 2023 | 12.63 |
September 28, 2023 | 12.43 |
September 27, 2023 | 13.68 |
September 26, 2023 | 13.78 |
September 25, 2023 | 14.17 |
September 22, 2023 | 14.52 |
September 21, 2023 | 15.07 |
September 20, 2023 | 15.07 |
September 19, 2023 | 15.57 |
September 18, 2023 | 15.77 |
September 15, 2023 | 16.67 |
September 14, 2023 | 17.02 |
September 13, 2023 | 16.87 |
September 12, 2023 | 16.67 |
September 11, 2023 | 17.52 |
September 08, 2023 | 18.67 |
September 07, 2023 | 17.07 |
September 06, 2023 | 17.52 |
September 05, 2023 | 19.29 |
September 01, 2023 | 19.12 |
August 31, 2023 | 18.87 |
August 30, 2023 | 19.51 |
August 29, 2023 | 19.46 |
August 28, 2023 | 19.17 |
August 25, 2023 | 20.06 |
Date | Value |
---|---|
August 24, 2023 | 19.44 |
August 23, 2023 | 20.11 |
August 22, 2023 | 19.71 |
August 21, 2023 | 19.81 |
August 18, 2023 | 21.61 |
August 17, 2023 | 21.86 |
August 16, 2023 | 20.81 |
August 15, 2023 | 20.66 |
August 14, 2023 | 21.61 |
August 11, 2023 | 36.93 |
August 10, 2023 | 36.88 |
August 09, 2023 | 37.13 |
August 08, 2023 | 36.53 |
August 07, 2023 | 37.08 |
August 04, 2023 | 37.48 |
August 03, 2023 | 38.53 |
August 02, 2023 | 39.33 |
August 01, 2023 | 37.43 |
July 31, 2023 | 45.62 |
July 28, 2023 | 47.81 |
July 27, 2023 | 47.46 |
July 26, 2023 | 51.56 |
July 25, 2023 | 51.01 |
July 24, 2023 | 54.65 |
July 21, 2023 | 55.30 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.302
Minimum
Jun 16 2022
59.14
Maximum
Jul 19 2023
8.148
Average
5.185
Median
Price to Book Value Benchmarks
Synlogic Inc | 0.5079 |
Cormedix Inc | 4.037 |
Bristol-Myers Squibb Co | 3.061 |
Verastem Inc | 4.067 |
Ocular Therapeutix Inc | 6.687 |
Price to Book Value Related Metrics
PS Ratio | 55.93 |
Price | 2.65 |
Earnings Yield | -231.7% |
Market Cap | 81.03M |